Authors:
Kawamoto, T
Shoda, J
Irimura, T
Miyahara, N
Furukawa, M
Ueda, T
Asano, T
Kano, M
Koike, N
Fukao, K
Tanaka, N
Todoroki, T
Citation: T. Kawamoto et al., Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder, CLIN CANC R, 7(5), 2001, pp. 1333-1342
Authors:
Shoda, J
Oda, K
Suzuki, H
Sugiyama, Y
Ito, K
Cohen, DE
Feng, L
Kamiya, J
Nimura, Y
Miyazaki, H
Kano, M
Matsuzaki, Y
Tanaka, N
Citation: J. Shoda et al., Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi, HEPATOLOGY, 33(5), 2001, pp. 1194-1205
Authors:
Itoh, S
Matsuzaki, Y
Kimura, T
Ikegami, T
Shoda, J
Fujiwara, M
Tanaka, N
Citation: S. Itoh et al., Cytokine profile of liver-infiltrating CD4(+) T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction, J GASTR HEP, 15(4), 2000, pp. 443-451
Authors:
Matsuzaki, Y
Sato, M
Saito, Y
Karube, M
Doy, M
Shoda, J
Abei, M
Tanaka, N
Hadama, T
Kinoshita, M
Citation: Y. Matsuzaki et al., The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: Etiological and molecular biological study (vol 18, pg 397, 1999), J EXP CL C, 19(1), 2000, pp. 125-125
Authors:
Itoh, S
Matsuzaki, Y
Kimura, T
Unno, R
Ikegami, T
Shoda, J
Doy, M
Fujiwara, M
Tanaka, N
Citation: S. Itoh et al., Suppression of hepatic lesions in a murine graft-versus-host reaction by antibodies against adhesion molecules, J HEPATOL, 32(4), 2000, pp. 587-595
Authors:
Nakajima, M
Yamato, S
Shimada, K
Sato, S
Kitagawa, S
Honda, A
Miyamoto, J
Shoda, J
Ohya, M
Miyazaki, H
Citation: M. Nakajima et al., Assessment of drug concentrations in tears in therapeutic drug monitoring:I. Determination of valproic acid in tears by gas chromatography/mass spectrometry with EC/NCI mode, THER DRUG M, 22(6), 2000, pp. 716-722
Authors:
Yoshida, T
Honda, A
Matsuzaki, Y
Shoda, J
Abei, M
Tanaka, N
Osuga, T
Citation: T. Yoshida et al., Plasma levels of mevalonate and 7 alpha-hydroxy-4-cholesten-3-one in chronic liver disease, J GASTR HEP, 14(2), 1999, pp. 150-155
Authors:
Matsuzaki, Y
Sato, M
Saito, Y
Karube, M
Doy, M
Shoda, J
Abei, M
Tanaka, N
Hadama, T
Kinoshita, M
Citation: Y. Matsuzaki et al., The role of previous infection of hepatitis B virus in HBs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: Etiological and molecular biological study, J EXP CL C, 18(3), 1999, pp. 379-389
Authors:
Tomida, S
Abei, M
Yamaguchi, T
Matsuzaki, Y
Shoda, J
Tanaka, N
Osuga, T
Citation: S. Tomida et al., Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: Acohort analysis, HEPATOLOGY, 30(1), 1999, pp. 6-13
Authors:
Shoda, J
Kano, M
Asano, T
Irimura, T
Ueda, T
Iwasaki, R
Furukawa, M
Kamiya, J
Nimura, Y
Todoroki, T
Matsuzaki, Y
Tanaka, N
Citation: J. Shoda et al., Secretory low-molecular-weight phospholipases A(2) and their specific receptor in bile ducts of patients with intrahepatic calculi: Factors of chronic proliferative cholangitis, HEPATOLOGY, 29(4), 1999, pp. 1026-1036
Authors:
Honda, A
Salen, G
Shefer, S
Batta, AK
Honda, M
Xu, GR
Tint, GS
Matsuzaki, Y
Shoda, J
Tanaka, N
Citation: A. Honda et al., Bile acid synthesis in the Smith-Lemli-Opitz syndrome: effects of dehydrocholesterols on cholesterol 7 alpha-hydroxylase and 27-hydroxylase activities in rat liver, J LIPID RES, 40(8), 1999, pp. 1520-1528
Authors:
Ikegami, T
Matsuzaki, Y
Shoda, J
Kano, M
Hirabayashi, N
Tanaka, N
Citation: T. Ikegami et al., The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A(2) expressionin colonic tissue, CANCER LETT, 134(2), 1998, pp. 129-139